Back

GLP-1 receptor agonists and risk of early and late recurrence after AF ablation in type 2 diabetes: an analysis from a global federated research network

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Atrial imaging and outcomes Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Leandra Serio

University of L'Aquila, Department of Clinical Medicine, Public Health, Life and Environmental Scien, L'Aquila (Italy)

5 More presentations in this session

Presentation thumbnail
Prediction of incident atrial fibrillation from a 10-second single-lead ECG using a neural network
Mr B. Holderied (Greifswald, DE)
Abstract Slides
Presentation thumbnail
Predictive value of TGF-β1 for new-onset atrial fibrillation following coronary artery bypass grafting
Mr J. Li (Beijing, CN)
Abstract Slides
Presentation thumbnail
Epicardial adipose tissue Glucagon-like peptide-1 receptor upregulation in human atrial fibrillation might be functionally offset by accompanying Phosphodiesterase-4 upregulation
Associate Professor A. Lymperopoulos (Fort Lauderdale, US)
Abstract Slides
Presentation thumbnail
Association of female sex with adverse clinical events in patients with new-onset post-operative atrial fibrillation: insights from the VISION cardiac surgery cohort
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Risk factors and electrocardiographic predictors associated with new-onset atrial fibrillation in hospitalized COVID-19 patients. Evaluation of a novel P-wave index.
Doctor P. Arvanitis (Uppsala, SE)
Abstract Slides

Access the full session

Session thumbnail
Atrial imaging and outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy of semaglutide in reducing atrial fibrillation recurrence post-catheter ablation: propensity score-matched analysis
1 April 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025
thumbnail
Congress Presentation
GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
23 May 2023
thumbnail
Congress Presentation
LVA ablation following the PVI strategy showed better outcomes in diabetic patients with wide LVA compared to narrow LVA: A Sub-Analysis of the SUPPRESS-AF Trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources